Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
34.83
Dollar change
+1.08
Percentage change
3.20
%
Index- P/E41.30 EPS (ttm)0.84 Insider Own15.47% Shs Outstand78.17M Perf Week2.11%
Market Cap2.72B Forward P/E9.63 EPS next Y3.62 Insider Trans-0.07% Shs Float66.12M Perf Month-21.32%
Income67.74M PEG4.69 EPS next Q0.55 Inst Own84.91% Short Float3.35% Perf Quarter-21.52%
Sales1.54B P/S1.77 EPS this Y2.99% Inst Trans1.29% Short Ratio3.44 Perf Half Y-8.46%
Book/sh20.31 P/B1.71 EPS next Y13.33% ROA1.77% Short Interest2.21M Perf Year-36.72%
Cash/sh3.95 P/C8.81 EPS next 5Y8.80% ROE3.99% 52W Range33.24 - 59.33 Perf YTD-20.02%
Dividend Est.- P/FCF37.27 EPS past 5Y3.10% ROI2.09% 52W High-41.29% Beta1.12
Dividend TTM- Quick Ratio2.18 Sales past 5Y1.17% Gross Margin58.30% 52W Low4.80% ATR (14)1.03
Dividend Ex-Date- Current Ratio3.45 EPS Y/Y TTM-60.96% Oper. Margin11.22% RSI (14)37.84 Volatility2.20% 3.17%
Employees5329 Debt/Eq1.06 Sales Y/Y TTM-1.03% Profit Margin4.39% Recom2.85 Target Price44.80
Option/ShortYes / Yes LT Debt/Eq1.04 EPS Q/Q-59.99% Payout0.00% Rel Volume1.63 Prev Close33.75
Sales Surprise-0.58% EPS Surprise-1.44% Sales Q/Q-0.25% EarningsFeb 28 BMO Avg Volume642.50K Price34.83
SMA20-1.67% SMA50-12.28% SMA200-14.11% Trades Volume1,030,976 Change3.20%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Upgrade Wells Fargo Equal Weight → Overweight $40 → $49
Nov-14-23Initiated CL King Buy $50
Aug-24-23Downgrade Morgan Stanley Equal-Weight → Underweight $44
Jul-12-23Upgrade Jefferies Hold → Buy $58 → $53
Jun-08-23Downgrade Argus Buy → Hold
May-24-23Downgrade JP Morgan Neutral → Underweight $56 → $43
May-23-23Downgrade Citigroup Neutral → Sell $59 → $39
Oct-12-22Initiated Jefferies Hold
Jul-25-22Initiated Morgan Stanley Equal-Weight $59
Apr-13-22Downgrade Truist Buy → Hold $72 → $71
Mar-13-24 08:17AM
Mar-12-24 12:04PM
Mar-11-24 08:30AM
Feb-29-24 11:46AM
10:43AM
05:52AM Loading…
05:52AM
Feb-28-24 10:46PM
09:30AM
07:15AM
06:32AM
06:28AM
06:25AM
06:00AM
06:00AM
Feb-27-24 05:03AM
09:15AM Loading…
Feb-26-24 09:15AM
Feb-21-24 10:00AM
Feb-07-24 09:15AM
Jan-20-24 03:19PM
Jan-10-24 07:13AM
Jan-05-24 04:30PM
Dec-14-23 11:14AM
Dec-13-23 06:15AM
06:04AM
Dec-12-23 12:00PM
Nov-24-23 11:31AM
Nov-08-23 08:00AM
Oct-26-23 10:52AM
08:20AM
Oct-25-23 09:30AM
08:06AM Loading…
08:06AM
07:15AM
06:13AM
06:00AM
Oct-13-23 11:40AM
Oct-11-23 06:53PM
Oct-10-23 05:38PM
Oct-05-23 08:25AM
Oct-04-23 08:00AM
Sep-28-23 11:49AM
Sep-27-23 05:56PM
Sep-07-23 07:37PM
Sep-01-23 05:04PM
Aug-31-23 08:37AM
Aug-25-23 11:31AM
10:26AM
Aug-13-23 05:49PM
Aug-10-23 08:51AM
Aug-07-23 02:28PM
Jul-28-23 11:12AM
Jul-26-23 08:00PM
07:45PM
06:39PM
06:30PM
11:04AM
Jul-24-23 01:51PM
10:00AM
Jul-20-23 10:02AM
Jul-13-23 01:07AM
Jul-11-23 10:50AM
Jul-03-23 04:45PM
Jun-29-23 08:39AM
Jun-28-23 04:15PM
Jun-21-23 04:15PM
Jun-12-23 04:08PM
07:20AM
Jun-08-23 07:11AM
06:56AM
Jun-05-23 06:44AM
May-30-23 08:07AM
May-24-23 03:02PM
02:33AM
May-23-23 03:52PM
May-15-23 07:58AM
06:37AM
May-11-23 04:30PM
May-03-23 07:00AM
Apr-27-23 10:34AM
Apr-26-23 11:08PM
04:27PM
09:30AM
07:15AM
06:00AM
Apr-06-23 08:37AM
Apr-03-23 08:00AM
Mar-31-23 10:36AM
Mar-30-23 01:05PM
12:50PM
Mar-23-23 07:54AM
Mar-20-23 08:00AM
Mar-03-23 03:57AM
Feb-23-23 08:05AM
05:17AM
Feb-22-23 07:25AM
06:00AM
Feb-16-23 06:05PM
10:01AM
Feb-15-23 10:00AM
Feb-14-23 10:40AM
Feb-09-23 07:30AM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
De Witte JanPresident & CEOMar 11 '24Option Exercise0.00205018,555Mar 13 04:30 PM
De Witte JanPresident & CEOMar 10 '24Option Exercise0.00346018,696Mar 12 05:12 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '24Option Exercise0.001,17901,179Mar 12 05:10 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Option Exercise32.598,736284,66358,241Mar 08 04:22 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Sale36.598,348305,49249,893Mar 08 04:22 PM
De Witte JanPresident & CEOJan 18 '24Option Exercise0.00597018,947Jan 19 04:43 PM
De Witte JanPresident & CEONov 01 '23Option Exercise0.009,814022,612Nov 03 04:27 PM
Mosebrook JeffreySVP, Fin & PAOAug 09 '23Sale44.461,17752,32923,458Aug 10 04:11 PM
De Witte JanPresident & CEOJun 01 '23Buy38.507,792299,98612,798Jun 02 04:10 PM
Schwartz EricEVP, Chief Legal Officer & SecJun 01 '23Buy37.892,640100,03548,597Jun 05 04:12 PM